Skip to main content
SpringerLink
Log in

Public–private partnership tackles TB challenges in parallel

  • News and Analysis
  • Published:

From Nature Reviews Drug Discovery

View current issue Sign up to alerts

Abstract

The Global Alliance for TB Drug Development and Tibotec have joined forces to develop a potential first-in-class drug for both drug-susceptible and drug-resistant tuberculosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Authors
  1. Sarah Webb
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Webb, S. Public–private partnership tackles TB challenges in parallel. Nat Rev Drug Discov 8, 599–600 (2009). https://doi.org/10.1038/nrd2955

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrd2955

  • Springer Nature Limited

This article is cited by

Search

Navigation